Novel Stem-Cell Therapy for a Type 1 Diabetes Cure Seeks FDA Approval for Clinical Trials
"Pending FDA approval of the applications, the early phase 1/2 clinical trial of VC-01 will enroll about 40 type 1 participants over a two-year period. The trial will primarily measure VC-01’s effect on C-peptide, a biomarker for insulin production. If all goes well, Viacyte hopes to bring this therapy to market by 2020. "
This is part of a new clinical trial that is slated to help find a (dare I say it) cure for type 1 diabetes. http://diatribe.org/issues/67/new-now-next/2 Exciting stuff!
Next Discussion: Three-Month At-Home Trial of Artificial Pancreas »